Faculty

Institution

Unit

Venue

Alexandra Sokolova, M.D.

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center For Hematologic Malignancies

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Alexandra Sokolova, M.d. is currently serving as a Biostatistics Shared Resources Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Alexandra Sokolova, M.D.

Oregon Health & Science University

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

You can click a keyword to filter the displayed items

prostate cancer urology oncology cancer care cancer research cancer treatment cancer genetics prostatic disease metastasis genitourinary cancers cancer genomics neurology genetics molecular diagnostics medicinal research oncogenes medicine pharmacotherapy molecular cancer surgical oncology metastatic prostate cancer tumor biology cancer imaging medical genetics genetic testing genomics jama oncology cancer biology tumor targeting anti-cancer agents bioinformatics neuro-oncology enzyme inhibition cohort studies drug targeting drug trials cancer management parp inhibitors genome biology clinical investigation precision medicine sequence analysis dna sequencing tumor heterogeneity social isolation loneliness genetic analysis treatment and prevention germline mutations medical internet research protein science plo biology surgical pathology rna biology functional modification genomic medicine enzyme specificity in vivo systems colorectal cancer mutagenesis next-generation sequencing genome sequencing excipients differential response cell-free dna dna repair genes clonal hematopoiesis somatic mutations caucasian men differential activity selection criteria survival outcomes chemorefractory dlbcl car t-cell therapy polymerase inhibitor sensitivity gene-by-gene granularity internal medicine translational research clinical laboratory gynecologic oncology bone marrow transplantation kidney cancer pathology nuclear medicine ovarian cancer gynecology translational medicine hematology haematopoiesis breast cancer individualized medicine leukemia laboratory medicine bladder cancer gynecologic cancers sarcoma lung cancer cancer letter carcinogenesis biomedical informatics thoracic oncology radiation oncology cancer discovery personalized medicine mesothelioma histopathology cancer cells molecular medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Association Between Smoking, Tumor Genetics, and Outcomes in Men With Metastatic Prostate Cancer.. Journal of Clinical Oncology (2026)

metastasiscancer carecancer geneticsurologyprostatic diseaseoncologyprostate cancer

Genomic Predictors of Response to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (Mcrpc): A Real-World Analysis From the Promise Registry.. Journal of Clinical Oncology (2026)

metastasiscancer careurologycancer genomicsprostatic diseasegenitourinary cancersmolecular diagnosticsoncologyoncogenescancer treatmentprostate cancer

Initial Findings From the Promise Registry, a Us Decentralized, Prospective Prostate Cancer Genetic Registry.. Journal of Clinical Oncology (2026)

cancer careurologypersonalized medicineoncologygenetic counselingprostate cancer

Ip43-17 the Utility of Enhanced Screening for People With Inherited Risk of Developing Aggressive Prostate Cancer in the Patrol Study. The Journal of Urology (2026)

cancer careurologymolecular diagnosticsoncologycancer screeningprostate cancer

Prospective Prostate Cancer Screening in Germline Pathogenic Variant Carriers: The Patrol Study.. Journal of Clinical Oncology (2026)

cancer careurologymolecular diagnosticsoncologycancer screeningprostate cancer

A Phase 1B, Open-Label, Multicenter Study of Xaluritamig in Patients With Biochemical Recurrence of Prostate Cancer After Definitive Therapy.. Journal of Clinical Oncology (2025)

Ben TranKevin Dale CourtneyAlexandra SokolovaLisa HorvathDaniel Costin DanilaJessica E. HawleyDavid William PookLandon Carter BrownYoung E. WhangSimon BuetikoferKejia WangNicholas Zorko

multicenter studybiochemical recurrencepharmacologydefinitive therapyurologyprostatic diseaseclinical researchoncologycancer treatmentprostate cancer

Approach to Treatment of Metastatic Hormone-Sensitive Prostate (Mhspc) Cancer Among Cooperative Oncology Groups (Cctg, Swog, and Alliance) in North America.. Journal of Clinical Oncology (2025)

metastasiscancer careurologypharmacotherapyprostatic diseaseoncologyprostate cancer

Barriers to Germline Genetic Testing in Advanced Prostate Cancer: Survey Results From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium (Pcctc).. Journal of Clinical Oncology (2025)

Alexandra SokolovaChanning Judith PallerEmmanuel S. AntonarakisPedro C. BarataJacob E BerchuckBurcu DarstVeda N. GiriRossella GraffeoFeighanne HathawayDaniel H. KwonStacy LoebRana R. McKayZachery R. ReichertMaria J. A. RibeiroAshwin SachdevaWalter StadlerMark N SteinMary-Ellen TaplinEmily Steinberger WegHeather H. Cheng

advanced prostate cancercancer geneticscancer researchgeneticsurologycancer genomicsmolecular diagnosticsclinical researchoncologygermline geneticscancer treatmentmedical geneticsgenetic testinggenetic epidemiologyprostate cancer

Baseline Hematological Parameters and Outcomes in Patients With Prostate Cancer Treated With Lu-177 Psma Radioligand Therapy (Rlt): A Multicenter Real-World Analysis. Clinical Genitourinary Cancer (2025)

baseline hematological parametersradiologycancer caremulticenter real-world analysisradiation oncologycancer researchclinical radiation oncologyurologyprostatic diseasegenitourinary cancerscancer imagingoncologyradiation therapynuclear medicineprostate cancer

Clinical Trial in Progress: Swog S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-Risk Prostate Cancer With Germline Brca1/2 Mutations. European Urology Focus (2025)

cancer geneticscancer careurologyprostatic diseasegenitourinary cancersoncologyoncogenescancer treatmentprostate cancer

1
2
3
4
5
6
7
10 / page

Alexandra Sokolova, M.D.

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Division Of Oncological Sciences

Center For Hematologic Malignancies

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Alexandra Sokolova, M.D.

Oregon Health & Science University

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Association Between Smoking, Tumor Genetics, and Outcomes in Men With Metastatic Prostate Cancer.. Journal of Clinical Oncology (2026)

metastasiscancer carecancer geneticsurologyprostatic diseaseoncologyprostate cancer

Genomic Predictors of Response to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (Mcrpc): A Real-World Analysis From the Promise Registry.. Journal of Clinical Oncology (2026)

metastasiscancer careurologycancer genomicsprostatic diseasegenitourinary cancersmolecular diagnosticsoncologyoncogenescancer treatmentprostate cancer

Initial Findings From the Promise Registry, a Us Decentralized, Prospective Prostate Cancer Genetic Registry.. Journal of Clinical Oncology (2026)

cancer careurologypersonalized medicineoncologygenetic counselingprostate cancer

Ip43-17 the Utility of Enhanced Screening for People With Inherited Risk of Developing Aggressive Prostate Cancer in the Patrol Study. The Journal of Urology (2026)

cancer careurologymolecular diagnosticsoncologycancer screeningprostate cancer

Prospective Prostate Cancer Screening in Germline Pathogenic Variant Carriers: The Patrol Study.. Journal of Clinical Oncology (2026)

cancer careurologymolecular diagnosticsoncologycancer screeningprostate cancer

A Phase 1B, Open-Label, Multicenter Study of Xaluritamig in Patients With Biochemical Recurrence of Prostate Cancer After Definitive Therapy.. Journal of Clinical Oncology (2025)

Ben TranKevin Dale CourtneyAlexandra SokolovaLisa HorvathDaniel Costin DanilaJessica E. HawleyDavid William PookLandon Carter BrownYoung E. WhangSimon BuetikoferKejia WangNicholas Zorko

multicenter studybiochemical recurrencepharmacologydefinitive therapyurologyprostatic diseaseclinical researchoncologycancer treatmentprostate cancer

Approach to Treatment of Metastatic Hormone-Sensitive Prostate (Mhspc) Cancer Among Cooperative Oncology Groups (Cctg, Swog, and Alliance) in North America.. Journal of Clinical Oncology (2025)

metastasiscancer careurologypharmacotherapyprostatic diseaseoncologyprostate cancer

Clinical Trial in Progress: Swog S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-Risk Prostate Cancer With Germline Brca1/2 Mutations. European Urology Focus (2025)

cancer geneticscancer careurologyprostatic diseasegenitourinary cancersoncologyoncogenescancer treatmentprostate cancer

1
2
3
4
5
6
7
10 / page